Recent studies have focused on the overlap of glucagon-like peptide-1|glucose-dependent insulinotropic polypeptide|GCGR agonist therapies and DA neurotransmission. While GIP stimulators are commonly employed for https://deaconisze962112.livebloggs.com/48163458/emerging-gcgr-stimulators-and-dopaminergic-influence-a-comparative-assessment